HTF Market Intelligence released a new research report of 80 pages on title ‘Global Precision Medicine Market (2018-2023)’ with detailed analysis, forecast and strategies. The study covers key regions that includes North America, South America, Asia, Europe, Other and important players such as Abbott Laboratories, GE Healthcare, GlaxoSmithKline etc.
Request a sample report @ https://www.htfmarketreport.com/sample-report/1304699-global-precision-medicine-market-11
Global Precision Medicine Market
Precision medicine is an upcoming approach which involves investigating whether a person has any diseases by evaluating the genetic makeup, and then diagnosing it. According to HTF MI, the global precision medicine market is expected to have a significant compounded annual growth rate (CAGR) of 9.7% and have a market size in excess of USD 96 Bn by 2023. North America dominates the global market due to the high incidence of cancer and increasing government initiatives in the region.
Precision medicine involves a study of patient specific information to diagnose, and then categorize various diseases. The concept of precision medicine is rapidly growing in the medicine community through tremendous expansion in various advanced technologies, such as next-generation sequencing, molecular biomarker analysis, and much more. With the help of growing technologies, precision medicine plays a vital role in preventing and treating various diseases such as cancer, cardiovascular, neurology and other diseases, which are currently burdening the healthcare system.
The global precision medicine market is classified into three primary segments – based on end use: pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies and healthcare IT specialists/big data companies; based on therapeutics: cancer, cardiovascular, central nervous system, psychiatric disorder and infectious diseases; and based on sub-market: big data analytics, bioinformatics, gene sequencing, pharmacogenomics and companion diagnostics.
View Detailed Table of Content @ https://www.htfmarketreport.com/reports/1304699-global-precision-medicine-market-11
Key growth factors
The concept of precision medicine has gained momentum in the healthcare community, powered by the tremendous expansion of various advanced technologies such as next-generation sequencing, molecular biomarker analysis and many more. Technological advancements have helped the precision medicine market prevent as well as treat diseases such as cancer, cardiovascular, neurology, diabetes, and others.
Rising pressure to lower healthcare cost globally, growth of personal healthcare devices, the emergence of value-based reimbursement models, and healthcare digitization trends are aiding the transition of treatment model from ‘one-size-fits-all’ to stratified and outcome-based targeted therapies, which are called precision medicine.
Threats and key players
Threat to personal data, high diagnostic costs, and the risk of hardware and software failure are some of the factors that will hinder the growth of the market.
The key players that have been contributing significantly to the precision medicine market include Abbott Laboratories, GE Healthcare, GlaxoSmithKline (GSK), Johnson & Johnson, Pfizer, Randox Laboratories, Almac Group, Novartis AG, Teva Pharmaceuticals Limited, CETICS Healthcare Technologies GmbH
What’s covered in the report?
1. Overview of the global precision medicine market
2. Market Drivers and challenges in the global precision medicine market.
3. Market Trends in the global precision medicine market
4. Historical, current and forecasted market size data for end use segment in the global precision medicine market (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies and healthcare IT specialists/big data companies)
5. Historical, current and forecasted market size data for the therapeutics segment in the global precision medicine market (cancer, cardiovascular, central nervous system, psychiatric disorder, infectious diseases)
6. Historical, current and forecasted market size data for the sub-market segment in the global precision medicine market (big data analytics, bioinformatics, gene sequencing, pharmacogenomics and companion diagnostics)
7. Analysis of the competitive landscape and profiles of major companies operating in the market
1. Get a broad understanding of the global precision medicine market, end uses, therapeutics, and the other sub-markets
2. Get geography-specific drivers and challenges affecting the global precision medicine market, its end uses, therapeutics, and the sub-markets
3. Devise market-entry strategies by understanding the factors driving the growth of the market
4. Identify the challenges and address them
5. Get insights into the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth
With the given market data, HTF MI offers customizations according to specific needs. Write to us at [email protected]
Make an enquiry before buying this Report @ https://www.htfmarketreport.com/enquiry-before-buy/1304699-global-precision-medicine-market-11
Chapter 1: Executive summary
1.1. Market scope and segmentation
1.2. Key questions answered in this study
1.3. Executive Summary
Chapter 2: Global precision medicine market – market overview
2.1. Global market overview – market trends, market attractiveness analysis, geography-wise market revenue (USD)
2.2. Global market drivers and challenges
2.3. Value chain analysis – precision medicine market
2.4. Porter’s Five Forces Analysis
2.5. Market segmentation based on end use (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies, healthcare IT specialists/big data companies)
2.6. Market segmentation for therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder, infectious diseases)
2.7. Market segmentation based on sub-market (big data analytics, bioinformatics, gene sequencing, pharmacogenomics, companion diagnostics)
Chapter 3: North America precision medicine market – market overview
3.1. Market overview – market trends, market attractiveness analysis, geography wise market revenue (USD)
3.2. North America – market drivers and challenges
3.3. Market segmentation based on end use (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies, healthcare IT specialists/big data companies)
Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=1304699
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.
Craig Francis (PR & Marketing Manager) HTF Market Intelligence Consulting Private Limited Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837 Phone: +1 (206) 317 1218 [email protected] Connect with us at https://www.linkedin.com/company/13388569/ https://www.facebook.com/htfmarketintelligence/ https://twitter.com/htfmarketreport https://plus.google.com/u/0/+NidhiBhawsar-SEO_Expert?rel=author
, Research Newswire, Press Release, North America, South America, United States, Latin America, United Kingdom, Europe, Africa, Asia, Middle East, English